Chronic kidney disease: Serious adverse effects associated with IV iron in CKD

Nature Reviews Nephrology 11, 506 (2015). doi:10.1038/nrneph.2015.112 Author: Susan J. Allison Iron-deficiency anaemia is very common in patients with chronic kidney disease (CKD). Primary findings from the REVOKE study now show that among nondialyzed patients with CKD and iron-deficiency anaemia, intravenous (IV) iron therapy is associated with an increased risk of serious adverse events, including infections
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Research Highlight Source Type: research